NTZnatalizumabADAbmultiple sclerosisOslo University HospitalpwMS
…University Hospital were switched from originator to biosimilar NTZ. We prospectively evaluated disease activity, safety, serum dru…
18articles mentioning drugs
57drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: natalizumab ×
natalizumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning natalizumab
18 articles · page 2 of 2natalizumabNTZNTZ-oDMTsmultiple sclerosisMSFlorencePIRA
…including RR-MS patients who received BEAM/ATG AHSCT or started natalizumab (NTZ, ie, controls) at our centre in Florence in the period 200…
AlemtuzumabnatalizumabocrelizumabRRMSCardiffrelapsing-remitting multiple sclerosisCambridge
…Introduction Alemtuzumab is a potent disease-modifying therapy (DMT) for relapsing-remit…
97.8%
natalizumabcyclophosphamiderituximabmultiple sclerosisMSplasma exchange
…lone and plasma exchange in intensive care and was commenced on natalizumab but deteriorated with a further reduction in level of conscious…
leflunomideadalimumabmethotrexatesekukinumabnatalizumaboral prednisoloneIV methylprednisolonemultiple sclerosispsoriatic arthritisMS
…ucing his pre-existing immunosuppression (ceasing methotrexate, leflunomide and oral prednisolone). A repeat MRI brain demonstrated signifi…
natalizumabocrelizumabrituximabmultiple sclerosisMShigh-efficacy therapymonoclonal antibodies
… were identified in three MS registries. Patients who commenced natalizumab, ocrelizumab, or rituximab between ages 12–17 into the early tr…